Details for New Drug Application (NDA): 209731
✉ Email this page to a colleague
NDA 209731 describes CLOVIQUE, which is a drug marketed by Chartwell Rx and is included in one NDA. Additional details are available on the CLOVIQUE profile page.
The generic ingredient in CLOVIQUE is trientine hydrochloride. There are ten drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the trientine hydrochloride profile page.
The generic ingredient in CLOVIQUE is trientine hydrochloride. There are ten drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the trientine hydrochloride profile page.
Summary for 209731
| Tradename: | CLOVIQUE |
| Applicant: | Chartwell Rx |
| Ingredient: | trientine hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 209731
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 250MG | ||||
| Approval Date: | Oct 21, 2019 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
